Gilead Sciences | Renteinntekt



Interest Income Endring Dato
AbbVie USD 92M 37M 2024-12
Agios Pharmaceuticals USD 18.02M 4.96M 2024-12
ALKERMES USD 0.88 10.92M 2024-12
Alnylam Pharmaceuticals USD 31.02M 1.13M 2024-12
Biogen USD 18.5M 6.9M 2024-12
BioMarin Pharmaceutical USD 17.68M 373K 2024-12
Eli Lilly USD 44.3M 3.5M 2024-12
Gilead Sciences 85M 33M 2024-12
GlaxoSmithKline 32M 8M 2024-09
Glaxosmithkline -28000000 60M 2024-12
Incyte 128.71M 128.71M 2024-12
J&J 292M 103M 2024-09
Merck USD 146M 19M 2024-12
Moderna USD 91M 12M 2024-12
Pfizer USD 171M 55M 2024-12
Regeneron Pharmaceuticals 8.12 3.42 2024-12
Sanofi 133M 41M 2024-09
Sarepta Therapeutics USD 7.88M 298K 2024-12
United Therapeutics USD 49.3M 500K 2024-12
Vertex Pharmaceuticals USD 128.2M 4M 2024-12



Gilead Sciences Renteinntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.